ARTICLE | Clinical News
Creon pancrelipase regulatory update
August 23, 2010 7:00 AM UTC
FDA approved an sNDA for Creon pancrelipase to include additional safety and efficacy data to treat exocrine pancreatic insufficiency due to cystic fibrosis (CF) in patients ages 7-11. The approval al...